Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2014 May;107(5):194–204. doi: 10.1177/0141076814522033

Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage

Arvind Singhal 1, Jack Ross 1, Olena Seminog 2, Keith Hawton 3, Michael J Goldacre 2,
PMCID: PMC4023515  PMID: 24526464

Abstract

Background

Psychiatric illnesses are known risk factors for self-harm but associations between self-harm and physical illnesses are less well established. We aimed to stratify selected chronic physical and psychiatric illnesses according to their relative risk of self-harm.

Design

Retrospective cohort studies using a linked dataset of Hospital Episode Statistics (HES) for 1999–2011.

Participants

Individuals with selected psychiatric or physical conditions were compared with a reference cohort constructed from patients admitted for a variety of other conditions and procedures.

Setting

All admissions and day cases in National Health Service (NHS) hospitals in England.

Main outcome measures

Hospital episodes of self-harm. Rate ratios (RRs) were derived by comparing admission for self-harm between cohorts.

Results

The psychiatric illnesses studied (depression, bipolar disorder, alcohol abuse, anxiety disorders, eating disorders, schizophrenia and substance abuse) all had very high RRs (> 5) for self-harm. Of the physical illnesses studied, an increased risk of self-harm was associated with epilepsy (RR = 2.9, 95% confidence interval [CI] 2.8–2.9), asthma (1.8, 1.8–1.9), migraine (1.8, 1.7–1.8), psoriasis (1.6, 1.5–1.7), diabetes mellitus (1.6, 1.5–1.6), eczema (1.4, 1.3–1.5) and inflammatory polyarthropathies (1.4, 1.3–1.4). RRs were significantly low for cancers (0.95, 0.93–0.97), congenital heart disease (0.9, 0.8–0.9), ulcerative colitis (0.8, 0.7–0.8), sickle cell anaemia (0.7, 0.6–0.8) and Down's syndrome (0.1, 0.1–0.2).

Conclusions

Psychiatric illnesses carry a greatly increased risk of self-harm as well as of suicide. Many chronic physical illnesses are also associated with an increased risk of both self-harm and suicide. Identifying those at risk will allow provision of appropriate monitoring and support.

Keywords: self-harm, suicide, physical illness, psychiatric illness, chronic illness, cohort study, risk, suicidality

Introduction

Self-harm is an important cause of admission to hospital, with over 200,000 admissions per year in England.1 Furthermore, people who self-harm have a substantially increased risk of suicide.2 The new National Suicide Prevention Strategy for England3 includes several priority groups including people with a history of self-harm, young people, and those living with long-term physical health conditions. The peak age for self-harm is 15–24 years,4 and suicide is the third leading cause of death in this age group.5

Psychiatric illnesses, especially depression, anxiety and alcohol misuse disorders, are well-known risk factors for self-harm.6 Associations between physical illness and self-harm are less well established, particularly in young people. Previous studies of adults have shown associations between suicidal behaviour and chronic physical illness, such as asthma, type I diabetes mellitus, epilepsy and cancer.710

We have investigated associations between specific psychiatric and physical illnesses and self-harm. We used hospital data on the English population to stratify long-term conditions by their relative risk of self-harm.

Method

Data sources and study population

We used a linked dataset of English Hospital Episode Statistics (HES) and mortality data for 1999–2011. HES is a nationwide dataset of routine statistical records of every day case and hospital admission in National Health Service (NHS) care in England (population 52 million in 2001, 56 million in 2011), supplied by the Health and Social Care Information Centre. This does not include A&E patients, unless admitted, or patient contacts in general practice. The mortality data are derived from hospital records and death registrations that were supplied by the Office for National Statistics. The linked dataset brings together all successive records for each individual in a time-sequenced data file.

Study design

Retrospective cohort studies were undertaken in the same way for each psychiatric and physical condition studied. The methods are described using depression as the example. A cohort was constructed of people who had been seen as a day case or admitted as an inpatient with a diagnosis of depression. For comparison with the depression cohort, a reference cohort was constructed of other people who had been either day cases or inpatients with a wide range of other, mainly minor, surgical and medical conditions and injuries (see Table 2 footnotes). The depression and reference cohorts were followed to identify subsequent day care for, hospital inpatient admission for, or death from, self-harm.

Table 2.

Risk of self-harm in patients with various medical and psychiatric conditions compared to the reference cohort*, number of observed cases of self-harm for each illness (n), ratio of rate (RR) with 95% confidence intervals (95% CI).

Conditions All years Within first year After first year
n RR* with 95% CI n RR* with 95% CI n RR* with 95% CI
Very high RR
 Depression 39,524 14.1 (14.0–14.3) 18,111 23.1 (22.6–23.7) 21,413 11.7 (11.5–11.9)
 Bipolar disorder 5733 11.6 (11.3–11.9) 2111 18.0 (17.2–18.8) 3622 9.7 (9.3–10.0)
 Alcohol abuse 39,878 8.0 (7.9–8.1) 15,061 12.8 (12.5–13.1) 24,817 6.7 (6.6–6.8)
 Anxiety and neurotic disorders 19,313 7.8 (7.7–8.0) 8913 13.6 (13.3–14.0) 10,400 6.0 (5.9–6.1)
 Eating disorders 2073 7.5 (7.2–7.9) 879 13.3 (12.4–14.3) 1194 5.7 (5.4–6.1)
 Schizophrenia 13,017 7.2 (7.1–7.4) 4350 11.4 (11.0–11.8) 8667 6.2 (6.0–6.3)
 Substance abuse 17,473 6.2 (6.0–6.3) 6274 8.6 (8.4–8.9) 11,199 5.4 (5.3–5.5)
High RR
 Epilepsy 10,256 2.9 (2.8–2.9) 2890 3.9 (3.8–4.1) 7366 2.6 (2.5–2.7)
 Asthma 31,700 1.8 (1.8–1.9) 7462 2.0 (1.9–2.0) 24,238 1.8 (1.8–1.8)
 Migraine 2547 1.8 (1.7–1.8) 677 2.0 (1.9–2.2) 1870 1.7 (1.6–1.7)
 Psoriasis 1141 1.6 (1.5–1.7) 284 1.7 (1.5–1.9) 857 1.6 (1.5–1.7)
 Diabetes mellitus 12,433 1.6 (1.5–1.6) 3191 1.6 (1.6–1.7) 9242 1.5 (1.5–1.6)
 Eczema 2047 1.4 (1.3–1.5) 517 1.7 (1.5–1.8) 1530 1.3 (1.3–1.4)
 Inflammatory polyarthropathies 4318 1.4 (1.3–1.4) 1209 1.5 (1.4–1.6) 3109 1.4 (1.3–1.4)
Neither high nor low RR
 Cystic fibrosis 132 1.0 (0.9–1.2) 17 1.1 (0.6–1.7) 115 1.0 (0.9–1.2)
 Coeliac disease 483 1.0 (1.0–1.1) 104 1.0 (0.8–1.2) 379 1.1 (1.0–1.2)
 Crohn's disease 1250 1.0 (1.0–1.1) 252 1.0 (0.9–1.1) 998 1.0 (1.0–1.1)
 Spina bifida 203 1.1 (0.9–1.2) 45 1.4 (1.0–1.9) 158 1.0 (0.9–1.2)
Low RR
 Cancers 8240 1.0 (0.9–1.0) 2639 1.1 (1.1–1.2) 5601 0.9 (0.9–0.9)
 Congenital heart disease 494 0.9 (0.8–0.9) 80 0.7 (0.6–0.9) 414 0.9 (0.8–1.0)
 Ulcerative colitis 1065 0.8 (0.7–0.8) 201 0.7 (0.6–0.8) 864 0.8 (0.7–0.8)
 Sickle cell anaemia 105 0.7 (0.6–0.8) 21 0.8 (0.5–1.2) 84 0.7 (0.5–0.8)
 Down's syndrome 26 0.1 (0.1–0.2) 9 0.2 (0.1–0.4) 17 0.1 (0.1–0.1)

*Conditions used in reference cohort, with office of population, censuses and surveys (OPCS) code edition 4 for operations and ICD10 code for diagnosis (with equivalent codes used for other coding editions): appendectomy (OPCS4 H01–H03), adenoidectomy (E20), dilation and curettage (Q10–Q11), hip replacement (W37–W39), knee replacement (W40–W42), squint (ICD10 H49–H51), cataract (H25), otitis (H60–H67), sebaceous cyst (L72.1) upper respiratory tract infections (J00–J06), varicose veins (I83), haemorrhoids (I84), deflected septum, nasal polyp (J33 + J34.2), impacted tooth and other disorders of teeth (K00–K03), inguinal hernia (K40), head injury (S06), in-growing nail, toenail and other diseases of nail (L60), contraceptive management (Z30), internal derangement of knee (M23), bunion (727.1), dislocations, sprains and strains (S03, S13, S23, S33, S43, S53, S63, S73, S83, S93), selected limb fractures (S42, S52, S62, S82, S92).

Adjusted for age in five-year bands, time period in single calendar years, region of residence and deprivation score associated with patients' area of residence, in quintiles.

At two decimal places, the RR was 0.95 (0.93–0.97).

Selection of cases

The International Classification of Diseases (ICD) codes used for the ‘risk factor’ diseases, such as depression, are shown in Table 1. The codes used to identify self-harm were E950–E959 (ninth revision of the ICD) and X60–X64, X66–X84 (10th revision). Patients with a hospital episode of care for depression and a care episode for one of the conditions in the reference cohort entered the depression cohort and were excluded from the reference cohort. Patients were excluded from the depression cohort if they had a hospital episode for self-harm before, or at the same time as, the admission for depression. The purpose of this was to ensure, as far as we could, that the exposure (depression) truly preceded the outcome (self-harm). We applied the same method for all conditions.

Table 1.

Number of people admitted to hospital with each condition (percentage who were female).

Conditions (ICD-10 codes) No. of people in exposure cohort (% of females)
Psychiatric
 Depression (F32.0–F32.2, F32.8–F32.9, F33.0–F33.2) 721,138 (63)
 Bipolar disorder (F31) 74,842 (60)
 Alcohol abuse (F10) 663,702 (28)
 Anxiety and neurotic disorders (F40–F48) 428,151 (63)
 Eating disorders (F50) 18,917 (87)
 Schizophrenia (F20–F29) 218,536 (46)
 Substance abuse (F11–F19) 383,063 (35)
Physical
 Epilepsy (G40–G41) 509,117 (49)
 Asthma (J45–J46) 2,500,814 (57)
 Migraine (G43) 147,330 (72)
 Psoriasis (L40) 119,304 (48)
 Diabetes mellitus (E10–E14) 2,230,207 (47)
 Eczema (L20–L30) 267,788 (52)
 Inflammatory polyarthropathies (M05–M09, M12–M14) 970,569 (66)
 Cystic fibrosis (E84) 7953 (48)
 Coeliac disease (K90.0) 69,746 (66)
 Crohn's disease (K50) 136,371 (56)
 Spina bifida (Q05) 14,563 (57)
 Sickle cell anaemia (D57.0–D57.2) 15,847 (52)
 Cancers (C00–C75, C81–C97) 3,202,099 (49)
 Congenital heart disease (Q20–Q24) 70,390 (50)
 Ulcerative colitis (K51) 19,1018 (49)
 Down's syndrome (Q90) 23,995 (46)

Data analysis

The rate of self-harm in the depression cohort was compared with that in the reference cohort, and expressed as a rate ratio (RR). The calculation was based on person-time (see Appendix [online supplementary material] for more details). In all analyses, the data were initially stratified by age (five-year groups), sex, year of admission (single years), region of residence (nine in England) and quintile of the index of multiple deprivation (a standard method of scoring socioeconomic status in England). The indirect method of standardisation was used taking the combined depression and reference cohorts as the standard population. All calculations were initially done within each stratum. For example, within each five-year age stratum, the rate in the combined depression–reference cohort was applied to the number of people in the same age stratum in the depression cohort, and, separately, applied to the number of people in the same age stratum in the reference cohort. This gave an ‘expected’ number of people with self-harm in the depression cohort, and an ‘expected’ number in the reference cohort. The observed and expected numbers in each stratum were then summed to give results in broader age groups and an all-ages-combined set of observed (O) and expected (E) numbers. The final RR is given by the formula (Odepr/Edepr) divided by (Oref/Eref), where O and E are the observed and expected numbers in the depression and reference cohorts. The RRs and their 95% confidence intervals (CIs) were calculated using standard methods.11

We further subdivided the results by whether the first episode for self-harm was within one year of admission to hospital or after a longer interval.

We undertook a separate analysis in which the end-point was death from suicide as the certified cause of death. This was identified from the relevant ICD codes on the death record (ICD-9 E950–E959 and ICD-10 X60–X84; we were not permitted access to data from coroners' verdicts as such). In this analysis, all deaths with these codes were included – those outside as well as those inside hospital.

Further details on methods is given in the Appendix (online supplementary material).

We ranked the psychiatric and physical conditions according to the size of the RR for self-harm. We defined levels of risk as very high or high empirically after examination of the results.

Results

Table 1 shows the number of people in the study by age group. In Table 2, the illnesses studied are ranked by their risk of admission for self-harm. Based on these RRs we arbitrarily defined categories of risk: those with very high risks of self-harm (RR >5), those with elevated risk of self-harm (RR <5, lower 95% CI >1), those with a neither high nor low risk (CIs that cross 1) and those with a reduced risk of self-harm (upper 95% CI <1). Figure 1(a) and (b) and the Supplementary Table show these data for males and females separately.

Figure 1.

Figure 1.

(a) Risk of self-harm in chronic illness in males ranked by rate ratios. Error bars represent 95% CIs (those with high or very high RRs had error bars that are too small to show meaningfully, see Table 2). Note the log scale on the horizontal axis. (b) Risk of self-harm in chronic illness in females ranked by rate ratios. Error bars represent 95% CIs (those with high or very high RRs had error bars that are too small to show meaningfully, see Table 2). Note the log scale on the horizontal axis.

Main findings

The psychiatric illnesses studied (depression, bipolar disorder, alcohol abuse, anxiety disorders, eating disorders, schizophrenia and substance abuse) all had RRs >5 (Table 2). The risk was elevated across all age groups (Table 3). Depression and bipolar disorder were associated with the highest risk of self-harm.

Table 3.

Age-specific risk of self-harm in patients with various medical and psychiatric conditions compared to the reference cohort*, number of observed cases of self-harm for each illness (n), ratio of rate (RR) with 95% confidence intervals (95% CI).

Conditions (ICD–10 codes) 10–24 years old 25–44 years old 45–64 years old ≥65 years old
n RR with 95% CI n RR with 95% CI n RR with 95% CI n RR with 95% CI
Psychiatric
 Depression 4216 12.4 (12.0–12.8) 18,344 16.7 (16.4–17) 12,606 19.7 (19.1–20.2) 4347 14.8 (14.2–15.5)
 Bipolar disorder 351 10.2 (9.2–11.3) 2618 11.1 (10.6–11.5) 2188 14.6 (14.0–15.3) 576 14.1 (12.9–15.4)
 Alcohol abuse 6516 3.8 (3.7–3.9) 19,990 10.6 (10.4–10.8) 12,017 12.1 (11.8–12.4) 1341 6.5 (6.1–6.9)
 Anxiety and neurotic disorders 2603 5.3 (5.1–5.5) 8977 8.7 (8.5–8.9) 5826 10.0 (9.7–10.3) 1900 8.4 (8.0–8.9)
 Eating disorders 973 5.9 (5.5–6.3) 902 10.1 (9.5–10.8) 184 13.2 (11.3–15.2) 14 6.6 (3.6–11.2)
 Schizophrenia 1832 8.0 (7.6–8.3) 7102 7.3 (7.2–7.5) 3397 8.7 (8.3–9.0) 681 6.2 (5.7–6.7)
 Substance abuse 3271 6.5 (6.3–6.8) 10,834 7.0 (6.8–7.1) 2927 5.8 (5.5–6.0) 435 4.1 (3.7–4.5)
Physical
 Epilepsy 1886 1.9 (1.8–2.0) 5075 3.7 (3.6–3.8) 2720 3.8 (3.7–4.0) 560 1.9 (1.7–2.0)
 Asthma 9144 1.7 (1.6–1.7) 13,485 2.1 (2.1–2.2) 6827 2.2 (2.1–2.2) 2196 1.4 (1.4–1.5)
 Migraine 712 1.5 (1.4–1.7) 1239 1.9 (1.8–2.1) 524 1.9 (1.7–2.1) 70 2.0 (1.5–2.5)
 Psoriasis 169 1.6 (1.3–1.8) 482 1.8 (1.6–2.0) 371 1.7 (1.5–1.9) 119 1.4 (1.2–1.7)
 Diabetes mellitus 1439 1.8 (1.7–1.9) 3496 2.2 (2.1–2.3) 4418 1.7 (1.7–1.8) 3072 1.2 (1.1–1.3)
 Eczema 714 1.3 (1.2–1.4) 685 1.5 (1.4–1.6) 437 1.7 (1.5–1.8) 205 1.4 (1.2–1.7)
 Inflammatory polyarthropathies 244 1.1 (1.0–1.3) 915 1.6 (1.5–1.7) 1666 1.6 (1.5–1.7) 1490 1.4 (1.3–1.5)
 Cystic fibrosis 102 1.4 (1.2–1.7) 24 0.7 (0.5–1.1) 6 2.0 (0.7–4.4) §
 Coeliac disease 109 1.0 (0.8–1.2) 156 0.9 (0.8–1.1) 159 1.2 (1–1.4) 59 1.4 (1.0–1.8)
 Crohn's disease 209 1.0 (0.8–1.1) 589 1.0 (0.9–1.1) 358 1.4 (1.2–1.5) 92 1.3 (1.1–1.6)
 Spina bifida 34 0.7 (0.5–1.0) 116 1.2 (1.0–1.4) 47 1.9 (1.4–2.5) 6 2.1 (0.8–4.5)
 Cancers 246 0.7 (0.6–0.8) 1226 0.8 (0.7–0.8) 2962 1.0 (0.9–1.0) 3799 1.1 (1.1–1.2)
 Congenital heart disease 214 0.8 (0.7–0.9) 158 0.9 (0.7–1.0) 95 1.2 (0.9–1.4) 26 1.2 (0.8–1.7)
 Ulcerative colitis 137 0.9 (0.7–1.1) 445 0.7 (0.7–0.8) 329 0.8 (0.7–0.9) 154 1.2 (1.0–1.4)
 Down's syndrome 5 0.1 (0.0–0.1) 10 0.1 (0.1–0.2) 10 0.2 (0.1–0.4) §
 Sickle cell anaemia 53 0.9 (0.7–1.2) 44 0.6 (1.5–0.9) 6 0.4 (0.2–0.9) §

*,See footnotes of Table 2.

§Data not shown for fewer than five observed cases.

Of the physical illnesses studied (Table 2), epilepsy, asthma, migraine, psoriasis, diabetes mellitus, eczema and inflammatory polyarthropathies were associated with an increased risk of self-harm. Cystic fibrosis, coeliac disease, Crohn's disease and spina bifida were associated with a neither high nor low RR. The association between cancers and self-harm was borderline significantly low (Table 2, footnote). The physical illnesses and conditions associated with a reduced risk of self-harm were congenital heart disease, ulcerative colitis, sickle cell anaemia and Down's syndrome.

The RRs for self-harm were highest in the year following admission for all of the psychiatric illnesses (Table 2). However, the subsequent RRs, though lower, were nonetheless also strikingly high. The physical disorders showed less of a difference between RRs in the first year and subsequent periods (Table 2). Cancers were associated with a borderline significant but very small increase in rate of self-harm in the first year after diagnosis (RR = 1.05, 95% CI 1.00–1.09), but a reduced incidence of self-harm after the first year (RR = 0.91, 95% CI 0.86–0.94).

Findings in the subgroups by age

We divided the cohorts into four age groups – 10–24 years, 25–44 years, 45–64 years and ≥65 years (Table 3) and compared each disease group with the control cohort within the same age range. The RRs for self-harm were highest for most illnesses in the 45–64 year-old age group. There were, however, some exceptions. Eating disorders had a particularly high risk of self-harm in 25–44-year-olds. Spina bifida showed a reduced RR (0.70) in the 10–24-year-old group and an increased RR (1.90) in the 45–64-year-old group. Coeliac disease and Crohn's disease were associated with an increased risk of self-harm in the 45–64-year-old group but no overall increased risk. Cancers and congenital heart disease were associated with a significantly low risk in people aged under 45 years, but, for cancers, with a high risk in people aged 65 years and over.

Findings in the subgroups by sex

We divided the cohorts by sex, as shown in Figure 1(a) and 1(b) and the Supplementary Table. Overall, the number of cases of admission for self-harm for men and women were broadly similar (101,370 men vs. 112,265 women). When considering individual illnesses, however, there were some marked differences in the number of male and female cases; for example there were many more female admissions with eating disorders (as expected), and many more male admissions with substance abuse (Table 1).

The RRs for self-harm were broadly similar for males and females for most illnesses, with some notable differences. Both Crohn's disease and cancer were associated with low risk ratios in females (RR = 0.91 and 0.87, respectively), but increased risk ratios in males (RR = 1.16 and 1.07, respectively). In general, the risk of admission for self-harm for most illnesses studies was higher in males than females (Supplementary Table).

Risk of suicide

RRs were calculated for suicide in each of the individual cohorts of psychiatric and physical illnesses compared with suicide in the reference cohort (Table 4). All psychiatric illnesses were associated with a substantially increased risk of suicide. The numbers of suicides in people with physical illnesses were quite small with wide CIs and, although we ranked them for the purpose of presentation, CIs commonly overlapped. For physical illnesses, the RRs for suicide were generally lower than those for self-harm overall. The exceptions to this were eczema, spina bifida, inflammatory bowel diseases and cancers. Epilepsy, asthma, eczema and cancers had a statistically significant (p < 0.05) increase in risk of suicide compared to the reference cohort.

Table 4.

Death from suicide in patients with various medical and psychiatric conditions compared to death in the reference cohort*: number of observed deaths (n), rate ratio for deaths (RR) with 95% confidence intervals (95% CI), and the ratio of all cases of self-harm to suicides.

Conditions n RR* with 95% CI Self-harm cases/suicides
Psychiatric
 Bipolar disorder 359 17.9 (16.0–20.0) 16.0
 Depression 1753 12.9 (12.2–13.7) 22.5
 Schizophrenia 905 10.6 (9.8–11.4) 14.4
 Anxiety and neurotic disorders 764 8.8 (8.2–9.6) 25.3
 Eating disorders 18 8.4 (5.0–13.4) 115.2
 Alcohol abuse 1027 4.7 (4.4–5.0) 38.8
 Substance abuse 562 4.7 (4.3–5.2) 31.1
Physical
 Epilepsy 257 1.8 (1.6–2.1) 39.9
 Eczema 67 1.4 (1.1–1.8) 30.6
 Migraine 39 1.3 (1.0–1.8) 65.3
 Psoriasis 45 1.3 (1.0–1.8) 25.4
 Asthma 662 1.2 (1.1–1.3) 47.9
 Cancers 857 1.2 (1.1–1.2) 9.6
 Coeliac disease 17 1.2 (0.7–1.8) 28.4
 Crohn's disease 50 1.2 (0.9–1.6) 25.0
 Spina bifida 6 1.2 (0.4–2.6) 33.8
 Inflammatory polyarthropathies 213 1.1 (1.0–1.3) 20.3
 Diabetes mellitus 626 1.0 (0.9–1.1) 19.9
 Ulcerative colitis 63 0.9 (0.7–1.2) 16.9
 Congenital heart disease 11 0.8 (0.4–1.4) 44.9
 Down's syndrome 3 0.4 (0.1–1.3) 8.7
 Cystic fibrosis 0 0.0 0
 Sickle cell anaemia 0 0.0 0

*,See footnotes of Table 2.

Table 4 also shows the ratio of suicides (the observed numbers in Table 4) to all self-harm events (the observed numbers in Table 2) for each illness. Overall, the ratio of self-harm events to suicides was 23. The ratio was particularly high for eating disorders and low for cancers.

Discussion

We found a strong link, as expected, between all of the psychiatric illnesses and self-harm. There was also an elevated risk for several physical illnesses studied – asthma, epilepsy, diabetes mellitus, migraine, psoriasis, eczema and inflammatory polyarthropathies – but at much lower levels of risk than for psychiatric disorders. Some physical illnesses were associated with a reduced risk of admission for self-harm; namely ulcerative colitis, cancer in young age groups, congenital heart disease, sickle cell anaemia and Down's syndrome.

Strengths and limitations

This study is based on all NHS hospital discharges, and all deaths, for the whole of England. To the best of our knowledge, this is the largest study examining chronic illness and self-harm. A particular strength is the fact that we have compared the risk of self-harm in people with different psychiatric and physical disorders within the same total population. Accordingly, the level of risk in the different disease groups is directly comparable.

The diagnoses of psychiatric and physical illness were made by doctors, as opposed to self-reported diagnosis, which means that the diagnosis is likely to be clinically reliable and free of reporting bias. It has previously been shown that discharge coding for non-fatal self-poisoning is accurate compared with that identified through a self-harm monitoring service.12

While the use of population data for all hospitals in England provides representative and reliable data, it has several limitations. We were only able to identify cases of self-harm that resulted in hospital admission or death, and that were identified as intentional self-harm. It is likely, for example, that where the attending doctor is uncertain whether an overdose was deliberate or accidental a diagnosis will be recorded and coded as an event of ‘undetermined intent’ (ICD10 codes Y10–Y34). Other possibilities in miscoding/misdiagnosis of self-harm are possible; people with diabetes may self-harm using insulin, for example, which may instead be coded as a hypoglycaemic attack. Our data for suicide were taken from ICD codes on death certificates rather than coroners' verdicts as we did not have access to the latter. Open verdicts, many of which are likely to be suicides,13 are not included. Self-harm and suicide are, therefore, likely to be under-reported in this study. However, this is the case for the reference cohort as well as the psychiatric and physical illness cohorts and may not impact much on the comparisons made between them.

With regard to physical illness, we were only able to identify cases where people were admitted to hospital for the disease investigated, which may exclude people whose disease is well controlled and do not require admission. Outpatients were not included. Accordingly, our findings may only apply to people whose illnesses were serious enough to warrant hospital admission.

Finally, HES lack detailed demographic data; while controls were matched by age, gender, socioeconomic status and location of residence, we could not take account of other confounders. There is also the issue of overlap between different diagnoses. We considered the possibility of studying risks in people with diseases in combination, e.g. diabetes with and without depression, but deemed it beyond the scope of the present study because of the large number of possible combinations. While this limits our ability to draw conclusions on inter-related causes, we believe that this does not diminish the aim of this study, namely to compare the risk of self-harm and suicide between different clinical conditions.

Comparisons with previous research

Psychiatric disorders are well known as risk factors for self-harm and suicide, and our findings are consistent with those of other investigators.6,14 Our findings of increased risk of self-harm in people with epilepsy, diabetes mellitus and asthma are consistent with previous findings.710 Psoriasis and migraine have also previously been associated with suicidal ideation in small studies.15,16

A recent Danish register-based case-control study showed epilepsy, asthma, cancer and diabetes mellitus were associated with a higher risk of attempted suicide in adolescents, but were not independent risk factors following adjustment for other confounders, such as socioeconomic class.17 In contrast, our study shows a reduced risk overall of self-harm in patients with cancer aged under 45 years. Previous studies in adults have shown an increased risk of suicide and attempted suicide in patients with cancer,18 while other studies on children and adolescents have not found an increased risk of suicide.19

There is a lack of data regarding Down's syndrome and self-harm, although suicide rates in people with learning disorders have been showed to be lower than average.20

Our data contrast with findings from elsewhere that inflammatory bowel disease is associated with an increased risk of suicide in adults.21

The ratio of overall self-harm to suicide was 23 in our study, which is slightly lower than reported elsewhere.22 This is likely to be because our study only including admitted patients. The particularly high ratio in individuals with eating disorders is probably because repetitive self-cutting is common in eating disorders.23

Mechanisms of association

Physical illness is often associated with mental illness.24 Also, childhood physical disorders, such as asthma and type I diabetes, have been shown to be associated with subsequent psychiatric disorders.25,26 In adulthood, migraine has been associated with depression and anxiety16 and dermatological disease with depression.15

The association between epilepsy and suicidal phenomena is well recognised. The possible mechanisms have been discussed by others27 and include a high prevalence of co-morbid psychiatric disease and a tendency towards lower socioeconomic status. Antiepileptic drugs have also been suggested to increase the risk of suicide, although the evidence is inconclusive.28

Depression and suicidal ideation have been shown to be more common in patients with inflammatory bowel disease than the general population in a Canadian study.29 However, we found that the incidence of self-harm was lower than average in patients with ulcerative colitis and neither high nor low in Crohn's disease overall.

Cancers had a slightly reduced risk of self-harm (RR = 0.95) but an increased risk of suicide (RR = 1.2). While younger age groups of cancer patients had a reduced risk of self-harm (Table 3), individuals aged over 65 years had a slightly increased risk (RR = 1.1). Notwithstanding the modest increased risk of suicide, one possible explanation for the generally low risk of self-harm in younger patients is that many people with cancer receive increased support and help. There was also a significant gender split, with males having a slightly increased risk of self-harm (RR = 1.07) but females having a reduced risk (RR = 0.87). This may be due to differences in the types of cancer in males and females, and support received. Breast cancer patients, for example, may receive greater psychological support than sufferers of other cancers.

Although Down's syndrome is associated with dementia, it appears to be protective against other psychiatric co-morbidity.30 Self-harm in patients with Down's syndrome was a very rare event, with only 26 cases overall (RR = 0.11). Possible explanations for this include increased supervision and a reduced capacity for self-injury.

There have been fewer large-scale studies on the association between other physical illnesses and suicidal phenomena, and consequently less evidence on possible mechanisms.

Conclusion

We have quantified the risk of admission to hospital for self-harm in patients with psychiatric and physical illnesses. While psychiatric illnesses were associated with a greatly elevated risk of self-harm, a moderately elevated risk was seen with common physical illnesses such as diabetes, epilepsy and asthma. Patients with psychiatric illness had a greatly increased risk of suicide while some physical illnesses such as epilepsy, asthma, eczema and cancers had a moderately increased risk.

The link between psychiatric illnesses and self-harm is well established, but associations between physical illnesses and self-harm are less well known. It is important for physicians to be aware of the physical disorders that are associated with an increased risk of self-harm so that at-risk individuals may be better identified and can be monitored for psychiatric symptoms and mental distress. This illustrates the need for greater integration of medical and mental health services.

Declarations

Competing interests

None declared

Funding

None declared

Ethical approval

Ethical approval for analysis of the record linkage study data was obtained from the Central and South Bristol Multi-Centre Research Ethics Committee (04/Q2006/176).

Guarantor

MG

Contributorship

AS, JR, OS and MG proposed the study, AS, JR, KH and MG designed the analysis, OS undertook the analysis, AS and KH reviewed the literature, JR designed the tables and figures, AS and JR interpreted the data and wrote the first draft, all authors contributed to the final draft.

Acknowledgements

The building of the linked dataset was funded by the National Institute for Health Research. The views expressed in this paper do not necessarily reflect those of the funding body. Keith Hawton is a National Institute for Health Research Senior Investigator.

Provenance

Not commissioned; peer-reviewed by Susham Gupta

References

  • 1.Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, et al. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 513–521 [DOI] [PubMed] [Google Scholar]
  • 2.Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry 2002; 181: 193–199 [DOI] [PubMed] [Google Scholar]
  • 3.Her Majesty's Goverment/Department of Health. Preventing Suicide in England: A Cross-Government Outcomes Strategy to Save Lives 2012; 57 See http://www.dh.gov.uk/health/files/2012/09/Preventing-Suicide-in-England-A-cross-government-outcomes-strategy-to-save-lives.pdf (last checked 15 January 2014 [Google Scholar]
  • 4.Bergen H, Hawton K, Waters K, Cooper J, Kapur N. Epidemiology and trends in non-fatal self-harm in three centres in England: 2000–2007. Br J Psychiatry 2010; 197: 493–498 [DOI] [PubMed] [Google Scholar]
  • 5.Galaif ER, Sussman S, Newcomb MD, Locke TF. Suicidality, depression, and alcohol use among adolescents: a review of empirical findings. Int J Adolesc Med Health 2011; 19: 27–35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Haw C, Hawton K, Houston K, Townsend E. Psychiatric and personality disorders in deliberate self-harm patients. Br J Psychiatry 2001; 178: 48–54 [DOI] [PubMed] [Google Scholar]
  • 7.Druss B, Pincus H. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med 2000; 160: 1522–1526 [DOI] [PubMed] [Google Scholar]
  • 8.Kyvik KO, Stenager EN, Green A, Svendsen A. Suicides in men with IDDM. Diabetes Care 1994; 17: 210–212 [DOI] [PubMed] [Google Scholar]
  • 9.Hawton K, Fagg J, Marsack P. Association between epilepsy and attempted suicide. J Neurol Neurosurg Psychiatry 1980; 43: 168–170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch Gen Psychiatry 2012; 69: 256–264 [DOI] [PubMed] [Google Scholar]
  • 11.Breslow N, Day N. Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies, Lyon: International Agency for Research in Cancer, 1987, pp. 82–119 [PubMed] [Google Scholar]
  • 12.Sellar C, Goldacre MJ, Hawton K. Reliability of routine hospital data on poisoning as measures of deliberate self poisoning in adolescents. J Epidemiol Community Health 1990; 44: 313–315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Linsley KR, Schapira K, Kelly TP. Open verdict v. suicide – importance to research. Br J Psychiatry 2001; 178: 465–468 [DOI] [PubMed] [Google Scholar]
  • 14.Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11–53 [DOI] [PubMed] [Google Scholar]
  • 15.Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846–850 [DOI] [PubMed] [Google Scholar]
  • 16.Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11–23 [DOI] [PubMed] [Google Scholar]
  • 17.Christiansen E, Stenager E. Risk for attempted suicide in children and youths after contact with somatic hospitals: a Danish register based nested case-control study. J Epidemiol Community Health 2012; 66: 247–253 [DOI] [PubMed] [Google Scholar]
  • 18.Allebeck P, Bolund C. Suicides and suicide attempts in cancer patients. Psychol Med 1991; 21: 979–984 [DOI] [PubMed] [Google Scholar]
  • 19.Möller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001; 19: 3173–3181 [DOI] [PubMed] [Google Scholar]
  • 20.Patja K, Iivanainen M, Raitasuo S, Lönnqvist J. Suicide mortality in mental retardation: a 35-year follow-up study. Acta Psychiatr Scand 2001; 103: 307–311 [DOI] [PubMed] [Google Scholar]
  • 21.Gradus JL, Qin P, Lincoln AK, Miller M, Lawler E, Sørensen HT, et al. Inflammatory bowel disease and completed suicide in Danish adults. Inflamm Bowel Dis 2010; 16: 2158–2161 [DOI] [PubMed] [Google Scholar]
  • 22.Hawton K, Harriss L. How often does deliberate self-harm occur relative to each suicide? A study of variations by gender and age. Suicide Life Threat Behav 2008; 38: 650–660 [DOI] [PubMed] [Google Scholar]
  • 23.Paul T, Schroeter K, Dahme B, Nutzinger DO. Self-injurious behavior in women with eating disorders. Am J Psychiatry 2002; 159: 408–411 [DOI] [PubMed] [Google Scholar]
  • 24.Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851–858 [DOI] [PubMed] [Google Scholar]
  • 25.Goodwin RD, Buka SL. Childhood respiratory disease and the risk of anxiety disorder and major depression in adulthood. Arch Pediatr Adolesc Med 2008; 162: 774–780 [DOI] [PubMed] [Google Scholar]
  • 26.Kovacs M, Goldston D, Obrosky DS, Bonar LK. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 1997; 20: 36–44 [DOI] [PubMed] [Google Scholar]
  • 27.Bell GS, Sander JW. Suicide and epilepsy. Curr Opin Neurol 2009; 22: 174–178 [DOI] [PubMed] [Google Scholar]
  • 28.Bagary M. Epilepsy, antiepileptic drugs and suicidality. Curr Opin Neurol 2011; 24: 177–182 [DOI] [PubMed] [Google Scholar]
  • 29.Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006; 12: 697–707 [DOI] [PubMed] [Google Scholar]
  • 30.Cooper S-A, van der Speck R. Epidemiology of mental ill health in adults with intellectual disabilities. Curr Opin Psychiatry 2009; 22: 431–436 [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES